Process for the inactivation of viruses with the aid of acridine derivatives
US6831086B1 · kind B1 · utility
5Cited by
2References
23Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 7, 1995 |
| Grant date | Dec 14, 2004 |
| Priority date | — |
| Expiry date | Mar 2, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18663
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The invention relates to the use of acridine or acridine derivatives, preferably in combination with benzalkonium chloride, for the inactivation of enveloped or nonenveloped viruses. The process according to the invention is preferably carried out in the presence of proteins whose biological activity is substantially retained.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.